Nordhealth AS is a cloud-based healthcare Software-as-a-Service business. Its flagship products are Provet Cloud and EasyPractice, both cloud-based Practice Management Software for veterinarians and therapists, respectively. It builds software that empowers healthcare professionals to improve patient care, increase efficiency and expand their business. The company has two operating segments namely: Veterinary and Therapy. It operates geographically in Norway, which derives maximum revenue, Finland, Sweden, Denmark, Germany and Other countries.
2021
361
LTM Revenue $565M
LTM EBITDA $34.8M
$245M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Nordhealth has a last 12-month revenue of $565M and a last 12-month EBITDA of $34.8M.
In the most recent fiscal year, Nordhealth achieved revenue of $3.3M and an EBITDA of -$0.1M.
Nordhealth expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Nordhealth valuation multiples based on analyst estimatesFY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $2.8M | $3.3M | $47.4M | $565M | XXX |
Gross Profit | $1.5M | $2.4M | $2.8M | XXX | XXX |
Gross Margin | 54% | 71% | 6% | XXX | XXX |
EBITDA | -$0.5M | -$0.1M | $2.2M | $34.8M | XXX |
EBITDA Margin | -17% | -2% | 5% | 6% | XXX |
Net Profit | -$0.4M | -$1.3M | -$1.0M | XXX | XXX |
Net Margin | -15% | -39% | -2% | XXX | XXX |
Net Debt | n/a | n/a | n/a | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 21, 2025, Nordhealth's stock price is NOK 38 (or $3).
Nordhealth has current market cap of NOK 3.0B (or $269M), and EV of NOK 2.7B (or $245M).
See Nordhealth trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$245M | $269M | XXX | XXX | XXX | XXX | $-0.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 21, 2025, Nordhealth has market cap of $269M and EV of $245M.
Nordhealth's trades at 5.1x LTM EV/Revenue multiple, and 82.1x LTM EBITDA.
Analysts estimate Nordhealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Nordhealth and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $245M | XXX | XXX | XXX |
EV/Revenue | 5.2x | XXX | XXX | XXX |
EV/EBITDA | 111.1x | XXX | XXX | XXX |
P/E | -32.8x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -78.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpNordhealth's NTM/LTM revenue growth is 17%
Nordhealth's revenue per employee for the last fiscal year averaged $9K, while opex per employee averaged $11K for the same period.
Over next 12 months, Nordhealth's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Nordhealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Nordhealth and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 1336% | XXX | XXX | XXX | XXX |
EBITDA Margin | 5% | XXX | XXX | XXX | XXX |
EBITDA Growth | -3841% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 22% | XXX | XXX | XXX | XXX |
Revenue per Employee | $9K | XXX | XXX | XXX | XXX |
Opex per Employee | $11K | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 117% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nordhealth acquired XXX companies to date.
Last acquisition by Nordhealth was XXXXXXXX, XXXXX XXXXX XXXXXX . Nordhealth acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Nordhealth founded? | Nordhealth was founded in 2021. |
Where is Nordhealth headquartered? | Nordhealth is headquartered in Norway. |
How many employees does Nordhealth have? | As of today, Nordhealth has 361 employees. |
Is Nordhealth publicy listed? | Yes, Nordhealth is a public company listed on OSL. |
What is the stock symbol of Nordhealth? | Nordhealth trades under NORDH ticker. |
When did Nordhealth go public? | Nordhealth went public in 2021. |
Who are competitors of Nordhealth? | Similar companies to Nordhealth include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
What is the current market cap of Nordhealth? | Nordhealth's current market cap is $269M |
What is the current revenue of Nordhealth? | Nordhealth's last 12-month revenue is $565M. |
What is the current EBITDA of Nordhealth? | Nordhealth's last 12-month EBITDA is $34.8M. |
What is the current EV/Revenue multiple of Nordhealth? | Current revenue multiple of Nordhealth is 5.1x. |
What is the current EV/EBITDA multiple of Nordhealth? | Current EBITDA multiple of Nordhealth is 82.1x. |
What is the current revenue growth of Nordhealth? | Nordhealth revenue growth between 2023 and 2024 was 1336%. |
Is Nordhealth profitable? | Yes, Nordhealth is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.